Here’s The Good, The Bad, And The Ugly Of The White House Health Plan

The White House's 'Great Health Care Plan' contains some good policies and some not-so-good ones.

Will Trump’s Free-Market Drug Pricing Solution Cut Out Greedy Middlemen?

An executive order instructs the HHS secretary to negotiate with drug manufacturers so that Americans pay the same low prices that others do.

Jill Biden’s $100 Million Women’s Health Initiative Won’t Make Up For The Ways This Administration Hurts Them

This administration has burdened women with many costs — costs that contribute to women remaining ignored, understudied, underfunded, and sick.

Have Lawmakers Found A Back Door To Extending Their Covid Tyranny?

A drug price transparency bill making its way through the Senate fails to protect against authorities accessing patient medical records.

Why Democrats Can’t Just Tack Drug Price Controls Onto Their ‘Infrastructure’ Bill

At a minimum, Democrats seem likely to have to rewrite their 'negotiation' legislation from scratch to address procedural concerns.